A First in Human Study of the Safety, Tolerability and Pharmacokinetics of PRV-002 in Healthy Volunteers

NCT05033444 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Traumatic Brain Injury (TBI)

Interventions

DRUG: PRV-002
DRUG: Placebo

Sponsor

Odyssey Group International, Inc.

Collaborators

[object Object]